Selected recent publications:
Nahvi S, Segal KS, Litwin AH, Arnsten JH. Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. Addiction Science and Clinical Practice. 2014, 13;9:9
Nahvi S, Blackstock O, Sohler NL, Thompson D, Cunningham CO. Smoking cessation treatment among office-based buprenorphine treatment patients. Journal of Substance Abuse Treatment. 2014, 47(2):175-9
Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH. Varenicline efficacy and safety among methadone maintained smokers: A randomized placebo-controlled trial. Addiction. 2014, 109(9):1554-63
Griffin J, Segal KS, Arnsten JH, Nahvi S. Barriers to telephone quitline use among methadone maintained smokers. Nicotine & Tobacco Research. 2015,17(8):931-6
Batchelder AW, Peyser D, Nahvi S, Arnsten JH, Litwin AH. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to Hepatitis C treatment. Drug and Alcohol Dependence. 2015, 153:66-71
Maradiaga J, Nahvi S, Cunningham CO, Sanchez J, Fox AD. "I kicked the hard way. I got incarcerated." Withdrawal from methadone during incarceration and subsequent aversion to medication assisted treatments. Journal of Substance Abuse Treatment. 2016, 62:49-54
Fitzgerald SA, Faseru B, Mussulman L, Howser E, Nahvi S, Goggin K, Cooperman NA, Richter KP. Improving quality of care for hospitalized smokers with HIV: Tobacco dependence treatment referral and utilization. The Joint Commission Journal on Quality and Patient Safety. 2016, 42(5):219-24
Shah PA, Cunningham CO, Blackstock OJ, Brisbane MT, Nahvi S. Use of smoking cessation methods among patients receiving office-based buprenorphine maintenance treatment. Journal of Addiction Medicine. 2017, 11(6):494-497
Adams TR, Arnsten JH, Ning Y, Nahvi S. Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use. Journal of Psychoactive Drugs. 2018, 50(1):12-18
Sohler NL, Starrels J, Khalid L, Bachhuber M, Arnsten JH, Nahvi S, Jost J, Cunningham CO. Marijuana use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain. Substance Use and Misuse. 2018, 17:1-6
Minami H, Brinkman HR, Nahvi S, Arnsten JH, Rivera-Mindt M, Wetter DW, Litvin Bloom E, Price LH, Vieira C, Donnelly R, McClain LM, Kennedy KA, D'Aquila E, Fine M, McCarthy DE, Thomas JG, Hecht J, Brown RA. Rationale, design and pilot feasibility results of a smartphone-assisted, mindfulness-based intervention for smokers with mood disorders: Project mSMART MIND. Contemporary Clinical Trials. 2018, 66:26-44
Weinberger AH, Pacek LR, Wall MM, Zvolensky MJ, Copeland J, Galea S, Nahvi S, Moeller SJ, Hasin DS, Goodwin RD. Trends in cannabis use disorder by cigarette smoking status in the United States, 2002 to 2016. Drug and Alcohol Dependence. 2018, 191:45-51
Nahvi S, Arnsten JH. Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders. Drug and Alcohol Dependence. 2018, 185: 245-247.